[Notice] Undefined index: HTTP_ACCEPT_LANGUAGE

GET /

Line 91 in /home/elchrom/www/silverstripe/public_html/biwac_autoLocale/code/AutoLocalePageExtension.php

Source

82                 // Kompabilitätsmodus: Qualität 1 annehmen

83                 $lang_quality = 1.0;

84             }

85 

86             // Bis der Sprachcode leer ist...

87             while (count($lang_code)) {

88                 // mal sehen, ob der Sprachcode angeboten wird

89                 if (in_array(strtolower(join('-', $lang_code)), $allowed_languages)) {

90                     // Qualität anschauen

91                     if ($lang_quality > $current_q) {

92                         // diese Sprache verwenden

93                         $current_lang = strtolower(join('-', $lang_code));

94                         $current_q = $lang_quality;

95                         // Hier die innere while-Schleife verlassen

96                         break;

97                     }

Trace

abc biopply - the abc in applied biomedicine
Webshop

Opening hours

Our office is closed from 24 December 2018
to 01 January 2019.

Opening hours, orders and shipments over the Festive Season:
- Last orders overseas: 5 December 2018
- Last orders Europe: 12 December 2018
- Last shipments intl: 12 December 2018
- Last shipment within CH: 18 December 2018

nach unten

3D CoSeedis™

Modular multi-purpose 3D Cell Co-Culture System

Discover
nach unten

3D CoSeedis™

Modular multi-purpose 3D Cell Co-Culture System

Discover
nach unten

3D CoSeedis™

Modular multi-purpose 3D Cell Co-Culture System

Discover
nach unten

The abc in Applied Biomedicine

abc biopply is an innovative, dynamic biotech company headquartered in Solothurn and with laboratory and research facilities in Cham, Switzerland.

The company was founded in 2015 with the aim to substantially improve and support the transition from scientific research to clinical applications.

abc biopply devotes its know-how and expertise in complex cell culture technologies to define and standardise workflows, technologies and protocols in translational medicine.

With 3D CoSeedis™ abc biopply presents a novel and innovative 3D cell culture system that fulfils our criteria in standardisation. Its unique features are:

  • Versatile applicability through standardised modular set-up
  • Standardised components ensure defined and reproducible experimental conditions
  • Validated workflows and protocols guarantee reliable readouts, hence comparable and reproducible results

 

About abc biopply

 

3D CoSeedis™

abc biopply - New Frontiers in Biostandardisation

Icon 01

3D CoSeedis™

...sets a new standard in 3D micro-organoid cultures.
Learn more
Icon 02

Services

...from abc biopply in biostandardisation
Learn more
Icon 03

Experts

...from our team await your questions
Learn more
Icon 04

Meet us

...at the following events
Learn more

3D CoSeedis™ convinces through its innovative modularity that allows us to grow cells in 3D aggregates that normally wouldn’t do so. It either supports aggregation through its unique topography or by the ability to grow feeder cells in a physically separated, distant manner. When investigating the response rate of various tumour cells to radiation, the 3D CoSeedis™ System allows us the flexibility and statistics that we need in experiments.

Dr. med. Andreas Thomsen, Facharzt für Strahlentherapie
Klinik für Strahlenheilkunde, Universitätsklinikum Freiburg i. B., Deutschland

3D CoSeedis™ offers the possibility to produce and collect exosomes in conditioned media from up to 900 spheroids per treatment in an easy and reliable manner. The unique topography of the 3D CoSeedis™ matrix further allows the aggregation of cells that would not do so in liquid overlay nor in hanging drop systems and therefore substantially extends the range of conditions media we can work with.

Dr. Peter Frost
CEO and Owner of FROST LIFESCIENCE, Germany

3D CoSeedis™ convinces through its innovative modularity that allows us to grow cells in 3D aggregates that normally wouldn’t do so. It either supports aggregation through its unique topography or by the ability to grow feeder cells in a physically separated, distant manner. When investigating the response rate of various tumour cells to radiation, the 3D CoSeedis™ System allows us the flexibility and statistics that we need in experiments.

Dr. Peter Frost
CEO and Owner of PeloBiotech GmbH, Germany

Contact us